Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD)

Table 3 Bivariate correlation analysis of NLR and PLR to other parameters in non-dialysis ESRD patients

	Neutrophil-to-lymphocyte ratio		Platelet-to-lymphocyte ratio
	rs	P	rs	P
Age (years)	0.177	< 0.0001	0.171	< 0.0001
Sex	0.038	0.350	−0.002	0.960
Albumin (g/L)	−0.075	0.07	−0.060	0.150
hs-CRP (mg/L)	0.377	< 0.0001	0.161	0.001
Ferritin (ng/mL)	0.140	0.003	−0.039	0.413
PCT (ng/ml)	0.285	< 0.0001	0.158	0.037
Leukocytes (10⁹/L)	0.510	< 0.0001	0.108	0.008
Neutrophils (10⁹/L)	0.691	< 0.0001	0.234	< 0.0001
Lymphocytes (10⁹/L)	−0.612	< 0.0001	−0.561	< 0.0001
Platelets (10⁹/L)	0.100	0.015	0.583	< 0.0001
Hemoglobin (g/L)	−0.18	0.658	0.069	0.094

NLR Neutrophil-to-lymphocyte ratio, PLR Platelet-to-lymphocyte ratio, ESRD End-stage renal disease, hs-CRP High sensitivity C-reactive protein, PCT Procalcitonin

ISSN: 1471-2369